Worldwide nearly 200 million people are infected with HCV. Close to 2% of the U.S. population are infected with HCV, and levels in some demographic groups are much higher. In most cases, exposure to HCV results in persistent chronic infection and the majority of cases remain undetected until symptomatic. Irnmunosuppression, whether due to co-infection with any of several pathogens or due to treatment, enhances HCV-mediated disease progression substantially. Hence HCV infection will remain a major long-term public health burden. Despite recent evidence that failure of the immune response early in HCV infection results in persistence, little is known of the first line defense, innate immunity. There is considerable information about peripheral blood T cells in HCV infection, but little is also known of the ~25% intrahepatic lymphocytes (IHL) that are 'NKT' (both T & NK cell markers). A major functionally-defined NKT subset, CDld-reactive NKT and target, CDld, are highly conserved and have roles in initiation and control of anti- viral responses, but can also cause model hepatitis. We have identified human hepatic CD ld-reactive NKT. This proposal will determine whether human hepatic CDld-reactive NKT in HCV infection have the functional potential to be pro-inflammatory. We will test the hypothesis that while CDld-reactive NKT naturally respond to infected CD 1d ? liver cells during acute anti-viral responses in a novel MHC class-I like path we have defined, their chronic stimulation contributes to liver pathology. Reciprocally, we also propose that hepatocytes can damage CDld-reactive NKT. Finally, we will also determine where the unique hepatic form of CDld is expressed in HCV infected liver.
Aim 1. Test the hypothesis that hepatic CDld-reactive NKT may serve as pro-inflammatory and pro- fibrotic cells in chronic HCV-mediated hepatitis and potentially contribute to liver i_ury.
Aim 2. Determine whether HCV infection increases CDld expression in vivo and enhances recognition of the hepatic form of CDld by hepatic CDld-reactive NKT in vitro. This study will provide information on whether the hepatic CDld-NKT cell 'axis' is a suitable target for novel therapeutic interventions in HCV infection and are complementary to others of the collaborators and P.I. on acute HCV infection in chimpanzees, as well as on liver immunology and on 'NKT' cells in general.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
3R01DK066917-04S1
Application #
7489769
Study Section
Special Emphasis Panel (ZRG1-GMA-2 (50))
Program Officer
Doo, Edward
Project Start
2004-09-01
Project End
2009-07-31
Budget Start
2007-08-01
Budget End
2008-07-31
Support Year
4
Fiscal Year
2007
Total Cost
$102,000
Indirect Cost
Name
Beth Israel Deaconess Medical Center
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02215
Mangan, Bozgana A; Dunne, Margaret R; O'Reilly, Vincent P et al. (2013) Cutting edge: CD1d restriction and Th1/Th2/Th17 cytokine secretion by human V?3 T cells. J Immunol 191:30-4
Yanagisawa, K; Yue, S; van der Vliet, H J et al. (2013) Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C. J Viral Hepat 20:556-65
Kornek, Miroslaw; Lynch, Michael; Mehta, Shruti H et al. (2012) Circulating microparticles as disease-specific biomarkers of severity of inflammation in patients with hepatitis C or nonalcoholic steatohepatitis. Gastroenterology 143:448-58
Rout, Namita; Greene, Justin; Yue, Simon et al. (2012) Loss of effector and anti-inflammatory natural killer T lymphocyte function in pathogenic simian immunodeficiency virus infection. PLoS Pathog 8:e1002928
Lynch, Lydia; Nowak, Michael; Varghese, Bindu et al. (2012) Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. Immunity 37:574-87
Li, Shaoyong; Vriend, Lianne E M; Nasser, Imad A et al. (2012) Hepatitis C virus-specific T-cell-derived transforming growth factor beta is associated with slow hepatic fibrogenesis. Hepatology 56:2094-105
Tun-Kyi, Adrian; Finn, Greg; Greenwood, Alex et al. (2011) Essential role for the prolyl isomerase Pin1 in Toll-like receptor signaling and type I interferon-mediated immunity. Nat Immunol 12:733-41
Exley, Mark A; Lynch, Lydia; Varghese, Bindu et al. (2011) Developing understanding of the roles of CD1d-restricted T cell subsets in cancer: reversing tumor-induced defects. Clin Immunol 140:184-95
Beziat, Vivien; Nguyen, Stéphanie; Exley, Mark et al. (2010) Shaping of iNKT cell repertoire after unrelated cord blood transplantation. Clin Immunol 135:364-73
Nowak, Michael; Arredouani, Mohammed S; Tun-Kyi, Adrian et al. (2010) Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with ?-galactosylceramide. PLoS One 5:e11311

Showing the most recent 10 out of 33 publications